3/4
08:12 pm
mdln
Medline Inc. announces pricing of secondary offering of class A common stock [Yahoo! Finance]
Medium
Report
Medline Inc. announces pricing of secondary offering of class A common stock [Yahoo! Finance]
3/4
08:00 pm
mdln
Medline Inc. announces pricing of secondary offering of class A common stock
Medium
Report
Medline Inc. announces pricing of secondary offering of class A common stock
3/3
07:02 am
mdln
Medline Inc. announces launch of secondary offering of Class A common stock
Low
Report
Medline Inc. announces launch of secondary offering of Class A common stock
3/2
11:54 am
mdln
Medline (MDLN) had its price target raised by Morgan Stanley from $48.00 to $52.00. They now have an "overweight" rating on the stock.
Low
Report
Medline (MDLN) had its price target raised by Morgan Stanley from $48.00 to $52.00. They now have an "overweight" rating on the stock.
2/27
11:41 am
mdln
Medline (MDLN) had its price target raised by Wells Fargo & Company from $42.00 to $47.00. They now have an "equal weight" rating on the stock.
Low
Report
Medline (MDLN) had its price target raised by Wells Fargo & Company from $42.00 to $47.00. They now have an "equal weight" rating on the stock.
2/26
08:29 pm
mdln
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... [Yahoo! Finance]
Medium
Report
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... [Yahoo! Finance]
2/26
03:41 pm
mdln
Medline (MDLN) had its price target raised by Citigroup Inc. from $48.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Medline (MDLN) had its price target raised by Citigroup Inc. from $48.00 to $60.00. They now have a "buy" rating on the stock.
2/26
01:36 pm
mdln
Medline (MDLN) had its price target raised by UBS Group AG from $48.00 to $57.00. They now have a "buy" rating on the stock.
Low
Report
Medline (MDLN) had its price target raised by UBS Group AG from $48.00 to $57.00. They now have a "buy" rating on the stock.
2/26
12:53 pm
mdln
Medline (MDLN) had its price target raised by BMO Capital Markets from $45.00 to $54.00. They now have an "outperform" rating on the stock.
Low
Report
Medline (MDLN) had its price target raised by BMO Capital Markets from $45.00 to $54.00. They now have an "outperform" rating on the stock.
2/26
10:52 am
mdln
Medline (MDLN) had its price target raised by Royal Bank Of Canada from $47.00 to $53.00. They now have an "outperform" rating on the stock.
Medium
Report
Medline (MDLN) had its price target raised by Royal Bank Of Canada from $47.00 to $53.00. They now have an "outperform" rating on the stock.
2/25
05:01 pm
mdln
Medline (MDLN) was given a new $55.00 price target by Stifel Nicolaus.
Low
Report
Medline (MDLN) was given a new $55.00 price target by Stifel Nicolaus.
2/25
04:07 pm
mdln
Medline (MDLN) was given a new $56.00 price target by Leerink Partners.
Low
Report
Medline (MDLN) was given a new $56.00 price target by Leerink Partners.
2/25
02:12 pm
mdln
Medline (MDLN) had its "outperform" rating reaffirmed by Evercore Inc.
Low
Report
Medline (MDLN) had its "outperform" rating reaffirmed by Evercore Inc.
2/25
08:03 am
mdln
Medline Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
Low
Report
Medline Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
2/25
07:30 am
mdln
Medline Reports Fourth Quarter and Full Year 2025 Results
Medium
Report
Medline Reports Fourth Quarter and Full Year 2025 Results
2/18
07:30 am
mdln
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
Medium
Report
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
2/5
10:58 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
1/28
09:00 am
mdln
Medline to report fourth quarter and full year 2025 results on February 25, 2026
Medium
Report
Medline to report fourth quarter and full year 2025 results on February 25, 2026
1/23
04:03 pm
mdln
Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]
Low
Report
Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]
1/21
10:11 am
mdln
Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..
Low
Report
Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..
1/21
09:04 am
mdln
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/15
07:47 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.